All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

Also called NCT05989074

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose other
Phase
Not applicable
Enrolled
  • 130 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05989074
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05989074. Randomized; single masking; primary purpose other. Start 2024-02-01 (anticipated); primary completion 2025-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve
Condition
Aortic Stenosis, Severe
Intervention (Device)
ALLEGRA TAVI System TF
Intervention (Device)
Ballon-expandable valve system
Lead sponsor
Ceric Sàrl (class: industry)
Collaborator
Biosensors International (class: other)
Collaborator
European Cardiovascular Research Center (class: research network)

Record details

Record id
cardio:ct-nct05989074
Content hash
48641f47c788c51eac31f0981cb60bfa533281a3265432c2d519fd3f46bfc37a